ME
Mesoblast
MESO
ASX - ALL MARKETSHealth Care
Income Statement
Total Revenue$19.85M
Gross Profit$19.85M
Operating Income$-186.67M
EBITDA$-257.39M
EBIT$-212.92M
Pre-tax Income$-197.04M
Net Income$-285.79M
Balance Sheet
Net Cash$1.3B
Cash Equivalent$60.38M
Total Debt$121.49M
Net Debt$-1.17B
Book Value$482.68M
Net Cash Per Share1.01
Book Value Per Share0.48
Key Ratios
Return on Equity (ROE)-18.31%
Return on Assets (ROA)-13.14%
Return on Invested Capital (ROI)-14.68%
Net Profit Margin-1490.27%
Current Ratio1.18
Quick Ratio1.15
Long-Term Debt / Equity0.21